Trials / Conditions / Leber's Hereditary Optic Neuropathy

Leber's Hereditary Optic Neuropathy

8 registered clinical trials studyying Leber's Hereditary Optic Neuropathy.

Status	Trial	Sponsor	Phase
Completed	Pupil Dynamics and Color Vision for the Detection of Eye Diseases NCT04909398	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts	N/A
Completed	A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for T NCT02693119	Stealth BioTherapeutics Inc.	Phase 2
Completed	Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy NCT02161380	Byron Lam	Phase 1
Completed	RHODOS Follow-up Single-visit Study NCT01421381	Santhera Pharmaceuticals	—
Completed	Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neu NCT00747487	Santhera Pharmaceuticals	Phase 2
Withdrawn	Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) NCT01495715	Santhera Pharmaceuticals	Phase 3
No Longer Available	Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the L NCT04381091	Santhera Pharmaceuticals	—
No Longer Available	Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] NCT02300753	Edison Pharmaceuticals Inc	—